Skip to content

Author

Jing-Na Wu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integration

This focused narrative review examines how biomarkers can distinguish established treatment eligibility from investigational strategies intended to address immune exclusion and resistance in triple-negative breast cancer.

Jing-Na Wu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.